BTTX Better Therapeutics, Inc.

Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

$6.82  +0.27 (4.12%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/29/2021
Outstanding shares:  23,599,718
Average volume:  1,081,561
Market cap:   $154,578,153
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   10.30
PS ratio:   0.00
Return on equity:   453.82%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy